Clinical Observation on Modified Yiqi Tongyang Decoction for 31 Cases of Chronic Idiopathic Thrombocytopenic Purpura

ZHU Huilan; DAI Linfeng; XU Yonggang

doi:10.13288/j.11-2166/r.2014.12.009

您当前的位置：

首页 >

文章列表页 >

Clinical Observation on Modified Yiqi Tongyang Decoction for 31 Cases of Chronic Idiopathic Thrombocytopenic Purpura

更新时间：2021-11-17

- Clinical Observation on Modified Yiqi Tongyang Decoction for 31 Cases of Chronic Idiopathic Thrombocytopenic Purpura
- Journal of Traditional Chinese Medicine Vol. 55, Issue 12, Pages: 1022-1024(2014)
- 作者机构：
  
  中国中医科学院西苑医院
- 作者简介：
- 基金信息：
- DOI：10.13288/j.11-2166/r.2014.12.009
  CLC： R259
- Published：2014
- 稿件说明：
移动端阅览
[1]朱会兰,戴林枫,许勇钢.益气通阳汤加减治疗慢性血小板减少性紫癜患者31例临床观察[J].中医杂志,2014,55(12):1022-1024.

ZHU Huilan, DAI Linfeng, XU Yonggang. Clinical Observation on Modified Yiqi Tongyang Decoction for 31 Cases of Chronic Idiopathic Thrombocytopenic Purpura[J]. Journal of Traditional Chinese Medicine2014, 55(12): 1022-1024.
[1]朱会兰,戴林枫,许勇钢.益气通阳汤加减治疗慢性血小板减少性紫癜患者31例临床观察[J].中医杂志,2014,55(12):1022-1024. DOI： 10.13288/j.11-2166/r.2014.12.009.

ZHU Huilan, DAI Linfeng, XU Yonggang. Clinical Observation on Modified Yiqi Tongyang Decoction for 31 Cases of Chronic Idiopathic Thrombocytopenic Purpura[J]. Journal of Traditional Chinese Medicine2014, 55(12): 1022-1024. DOI： 10.13288/j.11-2166/r.2014.12.009.

摘要

目的观察益气通阳汤加减治疗慢性血小板减少性紫癜（CITP）的临床疗效。方法 CITP患者31例服用益气通阳汤加减治疗

每日1剂

3个月为1个疗程

共治疗2个疗程。采用自身前后对照的方法

于治疗前及治疗1个疗程后、2个疗程后记录血小板计数、中医证候积分

判定西医临床疗效及中医证候疗效。结果治疗2个疗程后患者血小板计数较治疗前明显升高（P<0.05）。治疗1个疗程后及2个疗程后患者中医证候积分与治疗前比较均明显降低（P<0.01）。患者西医临床疗效总有效率为58.06%。治疗1个疗程后中医证候疗效总有效率为51.61%

2个疗程后总有效率为80.65%

治疗2个疗程后的总有效率明显升高（P<0.05）。结论益气通阳汤加减治疗CITP疗效确切

可显著改善患者中医证候及血小板计数。

Abstract

Objective To observe the efficacy of modified Yiqi Tongyang Decoction（ decoction to supplement qi and free yang） for chronic idiopathic thrombocytopenic purpura（ CITP）. Methods Totally 31 CITP patients orally took modified Yiqi Tongyang Decoction one dose daily. The treatment lasted for 2 treatment courses（ 6 months）. The platelet count and TCM syndrome score was recorded before treatment

after 1-course treatment and after 2-course treatment

respectively. The clinical efficacy and TCM syndrome efficacy was evaluated. Results The platelet count was significantly increased after 2-course treatment（ P < 0. 05）. The TCM syndrome score was significantly decreased after 1-course treatment and 2-course treatment（ P < 0. 01）. The clinical efficacy was 58. 06%. The TCM syndrome efficacy was 51. 61% after 1-course treatment and 80. 64% after 2-course treatment. The TCM syndrome efficacy was significantly increased after 2-course treatment（ P < 0. 05）. Conclusion Modified Yiqi Tongyang Decoction is effective for CITP

and it can obviously relieve TCM syndrome and improve platelet count.

关键词

Keywords

references

查看原文

Views

157

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Yinqiao Shengban Formula （银翘升板方） Adjuvant Therapy for Primary Immune Thrombocytopenia of 35 Cases：a Randomized Controlled Trial

HUANG Shilin’s Experience in Treating Idiopathic Thrombocytopenic Purpura

Clinical Observation on Shengxueling（生血灵） Formulations Combined with Western Medicine in Treating 30 Cases of Steroid Resistant Idiopathic Thrombocytopenic Purpura

The Philosophy and Practical Pathway of "Dao （道）-Shen （神）-Formula" in Traditional Chinese Medicine

A Preliminary Discussion on the Method of Regulating Qi and Calming the Mind

Related Author

LI Xiaohong

WANG Haimei

ZHANG Qianqian

SONG Junzhen

ZHANG Nan

LI Jing

WANG Yongmin

LI Ruijia

Related Institution

Graduate School， Hebei University of Chinese Medicine

Hebei Provincial Hospital of Traditional Chinese Medicine

Hebei Provincial Blood Center

Chengde Hospital of Traditional Chinese Medicine

The 210th Hospital of People’s Liberation Army

Address：No.16, Nanxiao street, Dongzhimen, Dongcheng District, Beijing Postal code：100700
Tel：010-64035632 Email：jtcmcn@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备09064830号-19 京公网安备11010102007558号
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰